| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Appropriateness of direct oral anticoagulant dosing for venous thromboembolism treatment
|
Tran, Emmeline
|
|
2017
|
43 |
4 |
p. 505-513
|
artikel
|
| 2 |
Association between CK-MB Area Under the Curve and Tranexamic Acid Utilization in Patients Undergoing Coronary Artery Bypass Surgery
|
Diepen, Sean van
|
|
2017
|
43 |
4 |
p. 446-453
|
artikel
|
| 3 |
Decompressive surgery in malignant cerebral venous sinus thrombosis: what predicts its outcome?
|
Mahale, Rohan
|
|
2017
|
43 |
4 |
p. 530-539
|
artikel
|
| 4 |
Determination of non-Vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system
|
Bliden, Kevin P.
|
|
2017
|
43 |
4 |
p. 437-445
|
artikel
|
| 5 |
Diabetes mellitus is associated with increased bleeding in pulmonary embolism receiving conventional anticoagulant therapy: findings from a “real-world” study
|
Zhang, Zhu
|
|
2017
|
43 |
4 |
p. 540-549
|
artikel
|
| 6 |
Effect of the FXa inhibitors Rivaroxaban and Apixaban on platelet activation in patients with atrial fibrillation
|
Steppich, B.
|
|
2017
|
43 |
4 |
p. 490-497
|
artikel
|
| 7 |
Effects of thromboprophylactic doses of apixaban and rivaroxaban on coagulation and thrombin generation in association with total hip replacement
|
Helin, Tuukka A.
|
|
2017
|
43 |
4 |
p. 562-569
|
artikel
|
| 8 |
Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study
|
Mantha, Simon
|
|
2017
|
43 |
4 |
p. 514-518
|
artikel
|
| 9 |
Etiology and complications of thrombocytopenia in hospitalized medical patients
|
Fountain, Eric M.
|
|
2017
|
43 |
4 |
p. 429-436
|
artikel
|
| 10 |
Evaluating the safety and effectiveness of venous thromboembolism prophylaxis in patients with sickle cell disease
|
Kelley, Denise
|
|
2016
|
43 |
4 |
p. 463-468
|
artikel
|
| 11 |
Evaluation of safety and effectiveness of standardized antifactor Xa-based unfractionated heparin protocols in obese versus non-obese patients
|
Isherwood, Manuel
|
|
2017
|
43 |
4 |
p. 476-483
|
artikel
|
| 12 |
Family history of venous thromboembolism and mortality after venous thromboembolism: a Swedish population-based cohort study
|
Zöller, Bengt
|
|
2016
|
43 |
4 |
p. 469-475
|
artikel
|
| 13 |
Implications of an inpatient warfarin dosing nomogram on safety outcomes post-discharge
|
Chamoun, Nibal
|
|
2016
|
43 |
4 |
p. 454-462
|
artikel
|
| 14 |
Intravenous thrombolysis for stroke after Dabigatran reversal with Idarucizumab: an update
|
Cappellari, Manuel
|
|
2017
|
43 |
4 |
p. 528-529
|
artikel
|
| 15 |
Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER®, RE-COVER™ II, and RE-MEDY™
|
Feuring, Martin
|
|
2017
|
43 |
4 |
p. 484-489
|
artikel
|
| 16 |
Oral antiplatelet drugs in patients with chronic kidney disease (CKD): a review
|
Ibrahim, Homam
|
|
2017
|
43 |
4 |
p. 519-527
|
artikel
|
| 17 |
Prospective evaluation of a bivalirudin to warfarin transition nomogram
|
Hohlfelder, Benjamin
|
|
2017
|
43 |
4 |
p. 498-504
|
artikel
|
| 18 |
Reduced anticoagulation variability in patients on warfarin monitored with Fiix-prothrombin time associates with reduced thromboembolism: The Fiix-trial
|
Oskarsdóttir, Alma Rut
|
|
2017
|
43 |
4 |
p. 550-561
|
artikel
|
Tijdschrift beschrijving